Related Experiment Video
Updated: May 11, 2026

Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 (Kir4.1)
Published on: September 26, 2015
OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas
Jinlong Shi1, Wei Shi, Lanchun Ni
1Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China. jl.shi@foxmail.com
Abstract:
Glioma is the leading cause of tumor-related mortality in the central nervous system. There is increasing evidence that the self-renewal capacity of cancer cells is critical for the initiation, growth and recurrence of tumors. OCT4 is a transcription factor that plays a key role in regulating the self-renewal ability of embryonic stem cells. DNA methylation is involved in the regulation of OCT4 expression during the development and differentiation of embryonic stem cells and neural stem cells. In the present study, we reported that OCT4 was highly expressed in primary gliomas and its expression levels increased in parallel with pathological grades. BSP analysis showed that the methylation levels of OCT4 gene promoter and exon were significantly reduced in comparison with the normal group and were negatively correlated with OCT4 gene expression in primary gliomas. In vitro, OCT4 gene expression was upregulated following treatment by a demethylation reagent in glioma cell lines. Our findings suggest that OCT4 is epigenetically regulated by DNA hypomethylation in primary gliomas, which may provide evidence for the role of DNA methylation in tumor and may present a new direction for developing more powerful strategies to treat glioma in the clinic.
Insights
OCT4, a key factor in stem cell self-renewal, is highly expressed in gliomas. DNA hypomethylation epigenetically regulates OCT4 in gliomas, offering potential new therapeutic targets.
Area of Science:
- Neuro-oncology
- Epigenetics
- Cancer Stem Cell Biology
Background:
- Glioma is a primary cause of brain tumor mortality.
- Cancer cell self-renewal is crucial for tumor initiation, growth, and recurrence.
- OCT4 is a transcription factor vital for stem cell self-renewal.
Purpose of the Study:
- To investigate the role of OCT4 expression and its epigenetic regulation in primary gliomas.
- To explore the relationship between DNA methylation and OCT4 expression in glioma development.
Main Methods:
- Analysis of OCT4 expression in primary gliomas.
- Bisulfite sequencing (BSP) to assess DNA methylation levels of the OCT4 gene promoter and exon.
- In vitro experiments using glioma cell lines treated with a demethylation reagent.
Main Results:
- OCT4 expression was significantly elevated in primary gliomas, correlating with higher pathological grades.
- Reduced methylation levels of the OCT4 gene promoter and exon were observed in gliomas compared to normal tissue.
- OCT4 gene expression increased after demethylation treatment in glioma cell lines, indicating upregulation.
Conclusions:
- OCT4 is epigenetically regulated by DNA hypomethylation in primary gliomas.
- These findings highlight the role of DNA methylation in glioma pathogenesis.
- This research may inform the development of novel glioma treatment strategies.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Somatic to iPS Cell Reprogramming
Abnormal Proliferation

